Condensed Consolidated Financial Statements Detail
|6 Months Ended|
Jun. 30, 2019
|Condensed Consolidated Financial Statements Detail [Abstract]|
|Condensed Consolidated Financial Statements Detail||
3. Condensed Consolidated Financial Statements Details
Long-term Equity Securities
As of June 30, 2019 and December 31, 2018, long-term equity securities consisted of an investment in Rezolute’s common stock of $1.1 million and $0.4 million, respectively (see Note 4). The Company recognized gains of $31,000 and $0.7 million due to the change in fair value of its investment in Rezolute’s common stock in the other income (expense), net line item of the condensed consolidated statements of operations and comprehensive loss for the three and six months ended June 30, 2019, respectively, and $0.4 million for the three and six months ended June 30, 2018.
Accrued and Other Liabilities
Accrued and other liabilities consisted of the following (in thousands):
Net Loss Per Share Available to Common Stockholders
Potentially dilutive securities are excluded from the calculation of diluted net loss per share available to common stockholders if their inclusion is anti-dilutive. The following table shows the weighted-average outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net loss per share available to common stockholders (in thousands):
The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.
No definition available.